KRT14 and cancer: These clinical in situ lesions displayed the same immunophenotype (positive for CK5/6, CK14, CK17 and EGFR, and negative for Her2/neu and ER/PgR) as the invasive basal-like cancer component, suggesting a common precursor lesion [39].